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Asymmetric Septal Hypertrophy in Patients With Aortic Stenosis:
An Adaptive Mechanism or a Coexistence of
Hypertrophic Cardiomyopathy?
OTTO M. HESS, MD, JAKOB SCHNEIDER, MD, MARCO TURINA, MD,
JOHN D. CARROLL, MD, FACC, MARTIN ROTHLIN, MD, HANS P. KRAYENBUEHL, MD
Zurich, Switzerland
Myocardial histologic features and leftventriculardy-
namics were assessed in 24 patients with severe aortic
stenosis, 12 with (group 1) and 12 without (group 2)
associated asymmetric septalhypertrophy.In 10patients
from group 1,echocardiographyshowed a septal/pos-
teriorwall ratio of 1.5; in the other 2, asymmetric septal
hypertrophywas diagnosed by direct inspection at the
time of surgery. Septal myectomy in all 12 patients in
group 1 was completed at the time of aortic valve re-
placement. Septal histologicfeatures were assessedfrom
surgical specimens in 10patients in group 1.Transseptal
endomyocardial biopsy specimens of theant rolateral
wall taken during preoperative cardiac catheterization
were evaluated by light microscopy in 10 patients from
group 1 and all patients of group 2.
Leftventricularend-diastolic and peak systolic pres-
sure, peak pressure gradient, calculated valve area and
angiographic muscle mass did not differ significantly in
groups 1 and 2; ejection fraction (68 versus 58%; prob-
ability [p]< 0.01) waslargerand end-diastolic volume
(109 versus 144 ml/m"; difference not significant[NS])
was smaller in group 1 than in group 2. Muscle fiber
diameter of theanterolateralwall was similar in groups
Asymmetricseptalhypertrophyhas been found to be the
characteristicabnormalityin patientswithhypertrophiccar-
diomyopathy(1-3). It is definedechocardiographicallyb
adisproportionalthicknessof theinterventricularseptum as
comparedwith the leftventricularposteriorwall.However,
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1 and 2 (26.5 versus 29.1IJ.; NS), but muscle fiber di-
ameter of the septum in group 1wassignificantlysmaller
(24.4IJ.; P < 0.01) than that of theanterolateralwall in
group 2. No morphologic abnormalities typical for hy-
pertrophic cardiomyopathy (fiberd sa ray)were seen in
samples from the patients in either group. By 18 months
postoperatively, septal wall thickness had decreased sig-
nificantly from 2.0 to 1.5 em (p< 0.01) and posterior
wall thickness from 1.4 to 1.2 cm (p< 0.05) in group
1. In group 2, septal wall thickness decreased from 1.5
to 1.3 em (NS) and posterior wall thickness from 1.4 to
1.2 em (NS) 8 months postoperatively.
Asymmetric septalhypertrophyin patients with aor-
tic stenosis is an adaptive mechanism to the long-stand-
ing pressure overload, and hence there is no evidence of
coexistenceof idiopathichypertrophiccardiomyopathy
and aortic valve disease. Although the degree of valve
obstruction was similar in both groups, leftventricular
ejectionperformance wassignificantlylower in the group
without asymmetrichypertrophy, probably becausethese
patients had a more advanced stage of myocardial dis-
ease. After successful valve replacement, there is a sig-
nificant regression of septalhypertrophyin patients with
aortic stenosis and asymmetric septalhypertrophy.
it can alsooccur in patientswith severe aortic stenosis
(4-8),and it has beensuggestedthat in these patients it is
due to acoexistenceof secondaryhypertrophyand hyper-
trophiccardiomyopathy.This hypothesiswas based on the
preoperativeechocardiographicfinding ofasymmetricseptal
hypertrophyin patientswith severe aortic stenosis(4,5).
In somepatients(5), histologicexaminationof theexcised
septal tissuedemonstratedmorphologicabnormalitiestyp-
c l of hypertrophicardiomyopathy.In anotherstudy,
Thompsonandco-workers(6) found noregressionof myo-
cardialhypertrophyaftersuccessfulvalvereplacement,and
intraventricularp essuregradientsin four of six patients
suggestedcoexistenceof hypertrophiccardiomyopathyand
aortic valvedisease.
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The purposeof the presentstudy was toexaminethe
histologic features of themyocardiumand leftventricular
hemodynamicsin 24 patientswith severe aortic stenosis,
12 with and 12 without asymmetric septal hypertrophy, in
order todeterminewhetherthelatterconditionis an adaptive
mechanism to the long-standing pressure overload or whether
it representsa combinationofbothsecondaryhypertrophy
andhypertrophiccardiomyopathy.
Methods
Studypatients.Twenty-fourpatients (7 women and 17 men)
with an average age of 51 years (range 25 to 69) were studied.
Twelve patients (group 1) had severe aortic stenosis with asym-
metric septalhypertrophy(mean systolic ventricular-aortic pres-
sure gradient 74 mm Hg, mean aortic valve area 0.69em",mean
aorticregurgitantfraction0.17),and 12 patients (group 2) had
severe aortic stenosis but noasymmetricseptal hypertrophy (mean
systolic pressure gradient 67 mm Hg, mean aortic valve area 0.74
ern",mean aorticregurgitantfraction0.18).The 24 patients with
severe aortic stenosis were selected from a cohort of 161 patients
with aortic stenosis with or without aortic regurgitation who under-
went cardiaccatheterizationduring the same time interval between
October 1977 and January 1982 as did our 24 patients. All patients
had M-modeechocardiography,and asymmetric septal hypertro-
phy was found in only 14 patients. Thus, the incidence of asym-
metric septalhypertrophyin our cohort of 161 patients with aortic
stenosis was9.0%.Two of the 14 patients with asymmetric septal
hypertrophy were,however,not included in the present study.
Coronary arteriography was carried out in all 24 patients.
There was a 50% stenosis of the left circumflex coronary artery
in only one patient from group 1; a 50% stenosis of the left anterior
descending coronary artery was detected in one patient from group
2. Minimal to mild mitralegurgitationwas present in three patients
from group 1(regurgitantfraction ranging from 0.05 to0.14).All
patients had sinus rhythm at thepreoperativeevaluation.
Echocardiography.M-mode echocardiograms(Organon
Teknika) were recorded shortly beforepreoperativecardiac cath-
eterization in theanteroposteriorposition or in the right anterior
decubitus position according to our standard technique (9). Left
ventricularinternaldiameter,shortening of the internal diameter,
septal wall thickness andposteriorwall thickness (Fig. I) as well
as heart rate wered terminedin all patients. Two-dimensional
echocardiograms(Varian V3(00)were obtained routinely in each
patient with M-modechocardiographyto confirm or exclude
asymmetric septalhypertrophyvisually from the two-dimensional
echocardiogram.This was done as it is known that a false positive
diagnosis ofasymmetricseptal hypertrophy can occur with M-
modeechocardiography,most commonly as a result of the ultra-
sonic beam passing vertically through the ventricular septum.
Moreover,asymmetricseptal hypertrophy was confirmed at the
time of surgery by direct inspection (see later). In two patients
from each group, the M-mode echocardiogram was not good enough
to provide adequate data and therefore was not included in the
present analysis. The ratio of septal to posterior wall thickness
described by Henry andco-workers(I,10) was used to define
asymmetry of the leftventricularhypertrophy as aseptal-posterior
wall ratio of 1.3 or greater. In the two patients of each group in
whom a good qualityechocardiogramwas not obtained, asym-
metric septal hypertrophy was diagnosed or excluded by left ven-
tricularcineangiographyor by visual and digital inspection of the
leftventricularoutflow tract during aortic valve replacement, or
by both.
M-mode andtwo-dimensionalechocardiographywere repeated
17.6 monthspostoperativelyin group I and 8.1 months postop-
eratively in group 2.Quantitativeevaluation of the M-mode echo-
cardiogramsincluded the same variables as during the preoperative
examination.However, in two patients from group I and in one
patient from group 2, a good qualityechocardiogramwas not
obtained.
Cardiaccatheterization.Informed consent was obtained from
all patients. Premedication consisted of 10 mg ofchlordiazepoxide
or of 5 mg of diazepam given orally I hour before the procedure.
Left ventricular pressure was measured in 24 patients by a Millar
7F-micromanometerthat had been advanced into the left ventricle
through a transseptally introduced 11.5 FBrockenbroughguiding
catheter (9). The patients then received intravenous heparin in a
dose of 10,000 units. Themicromanometerwas calibrated by
superimposing the micromanometer tracing with theconventional
pr ssure tracing (9,11).
Monoplane left ventricular cineangiography in the right ante-
rior oblique position was performed at midinspiration at a filming
rate of 50frames/soQuantitative evaluation ofend-diastolicand
end-systolic frames for the calculation of leftventricularvolumes
and ejection fraction was carried out according to our standard
technique(II). Left ventricular muscle mass wascalculatedac-
cording to the technique of Rackley et al. (12).
Left ventricularendomyocardialbiopsy.At the end of the
catheterization procedure, twoend myocardialbiopsies were per-
formed in 10 of the 12 patients from group I and m all patients
from group 2, using a King's College bioptome (9) introduced
into the left ventricle through theBrockenbroughguiding catheter.
The biopsy specimens were taken from theanterolateralwall of
the left ventricle, and other than transient prematureventricular
complexes during most biopsies, nocomplicationsoccurred in any
of the 22 patients. Immediately after the biopsy wasperformed,
the material was fixed inglutaraldehydeand embedded in Epon
for quantitative morphometry(9,13,14).The muscle fiber diameter
and the extent of interstitial fibrosis were determined from semi-
thin sections (1J.L). From several sections of each biopsy specimen,
the muscle fiber diameter wasdeterminedusing a mechanical-
optical pen (MOP, Kontron GmbH, Zurich). At least 100 measure-
ments were performed with this pen. The extent of interstitial
fibrosis was evaluated by usmg the point counting system (13). A
special ocular with a grid providing 100 intersection points was
used to determine the amount of fibrous tissue; more precisely,
the amount ofnonmuscularinterstitial tissue was evaluated by
counting the number of points overlaying interstitial tissue. To
term thisnonmuscularinterstitial tissue"interstitialfibrosis"is
somewhat incorrect, but because fibrous tissue is the largely pre-
dominantcomponentof the interstitial space, the term"fibrosis"
was used in this context. With this grid, usually 1,000 points were
ounted and the average interstitial fibrosis was calculated in all
patients who underwent biopsy.
With use of the same technique, the left ventricular muscle fiber
diameter was determined from septal myocardium obtamed from
ASYMMETRIC SEPTAL HYPERTROPHY J AM COLL CARDIOL
1983.1(3).783-9
785
ASYMMETRIC SEPTAL HYPERTROPHY
PW
RV
LV
IVS
PCG
ECG
I.K.c!19271/2 sec
SYMMETRIC HYPERTROPHY
7.6.79
AMV
-~. .' ' ''•..' 0· .•"''''' .' ." ..~ '. ' -.~ '. , ..;' e-a. ' Af ~:. .; .....~ , "
5em[
:. " , RV
IVS
AMV
LV
PW
. , , PCG
~ ECG
3.27.8 0 1/2 s ec D,M.? 19 19
Figure1. M-modeechocardiogramin a patientwithaor-
tic stenosis andasymmetricseptalhypertrophy(upper
panel) and a patient with aortic stenosis andymmetric
hypertrophyof the septum and the posterior wall (PW)
(lower panel). Theend-diastolic(ed) andend-systolic
(aortic valveclosure-As)wallthicknessof theinterven-
tricular septum (IVS) and posterior wall (PW) are mea-
suredjust belowthe mitralvalve. Notethedisproportion-
allythickenedinterventricularseptumin the upper panel
(septal/posteriorwall ratio 1.50) Theendocardialborder
of the septum and the posteriorwall in the upper panel
havebeenslightlyretouchedforillustrationpurposes.AMV
= anteriormitralvalveleaflet;ECG = electrocardiogram.
LV = leftventricle;PCG = phonocardiogram;RV =
rightventricle
10 of 12 patientswith septalmyectomyduring aortic valve re-
placement.In 2 ofthese 12patients,myocardialmaterial was not
availablealthoughseptalmyectomywascarriedout.
It is obviousthatquantitativeevaluationof endomyocardial
biopsyspecimensis limitedbecauseonly small samples of the left
ventricularmyocardiumareobtained.In patientswith aortic valve
disease,themorphologic hangesin themyocardiumare more or
less uniformlydistributedoverthe whole leftventricle(15),al-
though there might be some focalprocessesthat could affect our
quantitativeanalysis.The presentdata of the group I patients
show,however,that the leftventricularmuscle fiberdiameterin
theseptum(intraoperativematerial)and theanterolateralwall (en-
domyocardialbiopsy sample) aresimilar,suggestingthat the mus-
cle fiberdiametercan bedeterminedwith good accuracy from
biopsysamples.
To illustrate the different morphologic findings in patients with
hypertrophic cardiomyopathy (16) and patients with aortic valve
disease (15), we usedquantitativemorphometryto examine at
postmortem(Fig. 2) the heart of onepatientwho died of unsus-
pectedhypertrophicardiomyopathywith asymmetricseptalhy-
pertrophy(septal/posteriorwall ratio 2.0) and of a second patient
who died ofunsuspected,severe aortic stenosis withasymmetric
septalhypertrophy(septal/posteriorwall ratio 1.3). These hearts
were,however,fixed informalineand hence theabsolutevalues
of themorphologicdata are notdirectlycomparablewith those
obtainedfromendomyocardialbiopsies.
Aorticvalvereplacement.Severe alterations of the aortic valve
were found in all 24 patients at the time ofsurgery,and 5patients
from group I as well as 4 patients from group 2 had abicuspid
valve. All 24 patients showedcalcifications;in 13 of thesepatients,
thecalcificationextendedto the mitral anulus. Aortic valve re-
placementconsistedof theimplantationof abioprosthesis,ofeither
theCarpentier-Edwardstype (in eight patients from group I and
threepatientsfrom group 2) or theAngell-Shileytype (in four
patientsfrom group I and twopatientsfrom group 2). A me-
chanicalvalve of theBjork-Shileytype wasimplantedin five
patientsfrom group 2 and of the St. Jude Medical type inanother
twopatientsfrom group 2.
Septal myectomy was carried out by the transaortic approach
in all J2 patients in group J Intraoperatively,all 12patients
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Figure 2. Histologic section of the interventricular septum at postmort em
examination in a patient with aortic stenosis and asy mmetric septal hy-
pertrophy (left) and in a patient with asymmetric septal hypertrophy due
to hypertrophic cardiomyopathy (right) (magnification in both sec tions 125
X ). Moderate muscle fiber hypertrophy with slightly increased interstitial
fibrosis ( == seco ndary myocardial hypertrophy) is evident 10 the patient
with aortic stenosis , but severely hypertrophied muscle fibers, fiber disarray
(whirl formation) and enlarged nuclei are evident in the panent wuh hy-
pertrophi c cardiom yopathy . Thi s characteristic picture of hypertr ophic
cardiomyopathy was not see n In any of the 24 patients with aortic stenosis
in our series .
showed severe hypertrophy of the interventricular septum with
bulging into the leftventricular outflowtract.There were noserious
complications in any of the 24 patients operated on.
Statistics, Statistical comparisons between the two groups were
performed using the Wilcoxon test for two independent groups.
The pre- andpostoperative comparisons were carried out using the
Wilcoxon test for paired observations. The mean values ± I
standard deviation are given in all tables.
Results
Echocardiography (Table 1). Heart rate during routine
echocardiography did not differsignificantly in the twogroups.
Left ventricular internal diameter was slightly, although not
signifi cantly, larger in group 2 patients without asymmetric
septal hypertrophy than in group 1 patients (5.9 versus 5.2
cm). Left ventricular systolic shortening of the internal di-
ameter was, however, significantly smaller in group 2 than
ingroup I (34 versus 43%; probability [p] < 0.01). Posterior
wall thickness was similar in both groups, but both septal
wall thickness (2.0 versus 1.5 ern; p < 0.0 I) and septal!
posterior wall ratio (1.5 versus 1.1; P < 0.0 I) were sig-
nificantly larger in group I than in group 2. Systolic anterior
motion (SAM) of the anterior mitral leaflet was found in
five patients from group I and in none from group 2. In no
case did the anterior mitral leaflet reach the interventricular
septum, although the typical anterior movement described
by Henry et al. (10) was noted in these five patients.
In group I. the postoperative evaluation showed a sig-
nificant reduction in septal (2.0 before versus 1.5 ern after
operation; p < 0.01) and posterior wall thickness (1.4 before
versus 1.2 cm after operation; p < 0.05) as well as a sig-
nificant decrease in septal/posterior wall ratio (1.5 before
versus 1.2 after operation; p < 0.0 I). However, in group
2, there were no significant changes in septal or posterior
wall thickness after operation, probably because of the sig-
nifi cantly shorter mean postoperative observation time in
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Table 1. Echocardiographic Finding, Before (pre) and After (post) Operation
n HR DD Sh IVS PW IVS/PW
Group I
Pre 10 73 ± II 5.2 ± 0.7 r43 ± 10' r2.0 ± 041 14±0.2, rl.S ± 0.21Post * *10 79 ± 17 4.8 ± 0.4 37 ±12... I 5 ± 0 4~ 1.2 ± 03... 1.2 ± 0 3...
Group 2 s: s,,
L 1.5 ± 0.4Pre to 76 ± 16 5.9 ± 1 3 L34 ± 9 14 ± 0.2 LI.I ± 02
Post 11 84 ± 19 5.4 ± 1 0 32 ± 10 13 ± 0 1 1.2 ± 0 I 1.1 ± 0.1
* p < 005:t p < 001.given are mean value,:':: I standardeviauon.D" = lelt ventricularend-dra-tohcinternaldiametertcnu.HR = heart rate(beatvnum.IVS =
thickness of the Interventricular septum (em). IVS/PW= -eptal-povtenor wall rauo. po-t~ po-roperauve pre~ preoperative. PW= thrckne-,-,01 the povterun wall (cm)
Sh = systohc shortening of the left ventricular mternal diameter(clr)
group2 (8, I months)comparedwithgroupI (17.6months;
p < 0.005).The leftventricularinternaldiameterdid not
significantlychangein eithergrouppostoperatively;how-
ever,leftventricularsystolicshorteningof the internal di-
ameterdecreasedsignificantlyin group I from 43% pre-
operativelyto 37%postoperatively(p < 0.05),butremained
essentiallyunchangedin group2 aftersurgery.
Hemodynamics (Table 2). Leftventricularend-dias-
tolic and peaksystolicpressureas well as heart rate were
similarin the twogroups.Left ventricularend-diastolic
volume index waslightly,althoughnot significantly,el-
evatedin group2, and leftventricularejectionfraction was
significantlysmallerin group 2 than in group I (58 versus
68%; p < 0.01).Left ventricularmuscle mass index was
similarin both groups (191 versus 194g/rn";differencenot
significant[NS]).
Left ventricular morphology (Table 3). Theaveraged
muscle fiberdiameterof theanterolateralwall wassimilar
in both groups with aorticstenosis.Moreover,the muscle
fiberdiameteroftheanterolateralwall and theinterventric-
ularseptumdid notdifferin the group Ipatients.However,
themusclefiberdiameteroftheanterolateralwall was sig-
nificantlythickerin group 2 than themusclefiberdiameter
oftheinterventricularseptum in group I (29.1 versus24.4
u; p < 0.01).Typicalfeatures ofhypertrophicardiomy-
opathy(16), such as fiberdisarrayorseverelyhypertrophied
muscle fibers withvacuolesanddegeneratedmitochondria,
were not seen in any patient (Fig. 2). The mostcharacteristic
findings of ourbiopsiesin this group werehypertrophied
musclefibers withmoderateinterstitialfibrosis as seen typ-
ically insecondarymyocardialhypertrophy(15).
Illustrative cases(Fig.3). Wedeterminedthe left ven-
tricularmusclefiberdiameterof theinterventricularseptum
and theposteriorwall in thefollowingtwo patients: one
who died ofhypertrophiccardiomyopathyandanotherwho
died of severe aorticstenosis.Both patientsshowedthe
typicalfeaturesof asymmetricseptalhypertrophyat autopsy
with aseptal/posteriorwall ratioof 2.0 and 1.3, respec-
tively.FromFigure3, it isevidentthat with ypertrophic
cardiomyopathythemusclefiberdiameterof the septum is
significantlylargerthan that of theposteriorwall and is also
largerthan themusclefiberdiameterofthe septum and the
posteriorwall in thepatientwith aorticstenosis.Apparently,
the asymmetryof leftventricularhypertrophyis reflected
also at thecellularlevel inpatientswithhypertrophiccardio-
myopathy,whereasasymmetricseptalhypertrophyin pa-
tients with aorticstenosisis notaccompaniedby "abnor-
mally" thick septalmusclefibers.
Discussion
Echocardiographyhas been successfullyused in the
diagnosisof hypertrophicobstructivecardiomyopathywhen
asymmetrichypertrophyof the interventricularseptum
and anarrowoutflowtractand systolicanteriormotion
of the mitralvalve were observed(1-3). However,in
somepatientswithsevereaorticstenosis(4-8) coexisting
asymmetricseptalhypertrophywas noted.This coexist-
Table 2. Hemodynamic Data
HR LVEDP LVSP EDVI EF LMMI
Group I
(n = 12) 80 ± II 185 ± 13 217 ± 38 109 ± 50 68 ::':: 7l 191 ::':: 51
Group 2 ...
(n = 12) 78 ± 14 175± 8 213 ± 32 144 ± 67 58 ± J 194 ::':: 66
IS
* p < 0.01.given are mean valuesc; I standard devianon. EDVI= left ventricularend-dra-tohcvolume index(ml-nr'),EF ~ lelt ventricular election tracuon('Ir). HR
= heart rate (beats/min): LMMI= left ventricular musclerna" mdex(g/m).LVEDP = lett ventricular end-dravtohcpre"ure(rnm Hg) LVSP ~ lett ventricularpea,
systolic pressure (mm Hg)
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Table3.MorphologicFindings
MFD, n, IF nlF MFD, n,
Group 1
(n = 10) 26.5 :t 5.3 120 :t 77 17 7 :t 6 822 :t 356 24.4 :t 4.5 123 ::: 54
Group 2
(n = 12) 29. 1:t 2.3 106 :t 25 18.6 :t 6 975 ::: 87
Given are mean values± I SO: IF = left ventricular Interstitialf brosis(o/{). MFD , = leftventricular musclefiberdiameter of the anterolateralwall (p. ) . MFD, = left
ventricularmuscle fiberdiameterof theinterventricularseptum (p.). n, = number ofmeasurementsperformed, n.,= number ofporntscounted. n,= number ofmeasurement'
performed
Figure 3. Muscle fiber diameter of the interventncular septum(lVS) and
posterior wall (PW) at postmortem in a patient with aortic stenosis (AS)
with asymmetric septal hypertrophy (ASH) (solid line) and111 a patient
with asyrnrnetnc septal hypertrophy due to hypertrophic cardiomyopathy
(HOeM) (dotted line ). Note that the fiber thickness of the postenor wall
in both patients and the fiber thickness of the septum111 the patient with
aorncstenosis are Similar, whereas the fiber thickness of the interventricular
septum in the patient with cardiomyopathy is sigruficantly shifted to the
right to higher fiber diameters. In each patient, multiple measurements of
muscle fibers were performed (n:%)
ence of aortic valve disease and asymmetric septal hy-
pertrophy has been shown as a rare combination of aortic
valve disease and hypertrophic cardiomyopathy; in one
study (5) the excised septal tissue showed the character-
istic morphologic abnormalities of hypertrophic cardio-
myopathy and another study (6) demonstrated an intrav-
entricular pressure gradient late after successful valve
replacement. Therefore, we undertook a retrospective study
using myocardial biopsy samples to determine whether or
not asymmetric septal hypertrophy in patients with aortic
valve disease truly represents coexistence of hypertrophic
cardiomyopathy and aortic valve disease or is an adaptive
mechanism to the long-standing pressure overload.
Significance of asymmetricseptalhypertrophyin se-
vere aortic stenosis. Our present data show that the mor-
phologic features of the interventricular septumand anterior
wall are identical in patients who have both severe aortic
stenosis and asymmetric septal hypertrophy; the morpho-
_ AS WITH ASH
....HOCM
ogic alterations found in severe aortic stenosis are similar
in patients with and without asymmetric septal hypertrophy.
Thus, our data document a uniform hypertrophy of the sep-
tum and anterolateral wall in patients with both aortic ste-
nosis and asymmetric septal hypertrophy; the latter is con-
sidered tobesecondaryto the long-standing pressureoverload
of th left ventricle. The characteristicfindings of hyper-
trophic cardiomyopathy were not seen in the asymmetrically
hypertrophied septum in patients with aortic stenosis; sim-
ila ly there was no difference between the muscle fiber di-
ameter of the septum and the anterolateral wall.
Factorsproducingasymmetricseptalhypertrophy.
The questions now arise of why the septum is more hy-
pertrophiedthan the rest of the left ventricle, and why some
patients with aortic stenosisdo and some do not showasym-
m tric septal hypertrophy. In response to these questions,
one might speculate thatasymmetricseptal hypertrophy is
the result of mechanical factors because the left ventricle is
smaller in those patients with aortic stenosiswho have asym-
metric septal hypertrophy than in those without it (Tables
I and 2). Therefore, the left ventricle is more like a slit
with a straight septum and no curvature. and regional wall
stress might be greater in the septum than in the posterior
wall. Thus. the increased wall mass in the septum could
represent a compensatory mechanism to prevent highly ab-
normal septal wall stresses. The postoperative echocardi-
ogr msafter removal of the pressure burden showthatasym-
metry of left ventricular hypertrophy'tends to be normalized
mainly by a decrease in septal muscle mass. The patients
without asymmetric septal hypertrophy were characterized
by a slightly reduced left ventricular ejection performance.
which probably reflects a more advanced stage of myo-
cardial disease due to a longer duration of the pressure
overload. This hypothesis of a particularly advanced sec-
ondary hypertrophy in these patients is also in agreement
with ourfindingthat musclefibers of the anterolateral wall
in group 2 were thicker than the musclefibersof the septum
in group I (Fig. 4).Apparently, asymmetric septal hyper-
trophy is beneficial for maintaining normal left ventricular
ejection performance.
Role of septal myectomy. Asymmetric septal hypertro-
phy might have not only a physiologic importance by com-
pensating for the severely increased afterload in patients
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with aortic stenosis but also anadversereaction when the
pressureburden isremovedaftersuccessfulvalve replace-
ment. The removalof a fixedobstructionmay unmask or
aggravatea functionalobstruction(8) in patients with asym-
metric septalhypertrophy ("ASH-crash"). Therefore. sep-
tal myectomy wasperformedin all 12 patients with asym-
metric septal hypertrophyto prevent left ventricular outflow
tract obstruction early after aortic valvereplacement.
Figure4. Muscle fiber diameter of theanterolateralwall (AW) and in-
terventncularseptum (IVS) in 10 patients with aortic stenosis (AS) and
asymmetric septal hypertrophy (ASH) andIn 12patient,with aoruc stenosis
but no asymmetncseptal hypertroph y. Note that the values for muscle
fiber diameter of the anterolateral wall and the interventricular septum in
the 10 patients with aornc stenosis and asymmetric septal hypertroph y are
not significantly different , and are comparable With the value, for fiber
diameterof theanterolateralwallIn patients with aortic stenosis without
asymmetricseptal hypenrophy However, the fiberdiameterof the anter-
olateral wall in the lauerpauents is significantl y thicker than the muscle
fiberdiameterof theinterventricularseptum in patients With aortic stenosrs
and asymmetric septal hypertroph y. NS= not Significant; P= probability
(Wilcoxon test).
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